Vagus nerve stimulation in a case of epilepsy with CSWSS: respiratory side effects during sleep.
D000367:Age Factors; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001569:Benzodiazepines; D002648:Child; D000078306:Clobazam; D003131:Combined Modality Therapy; D004599:Electric Stimulation Therapy / Q000009:adverse effects* / Q000379:methods*; D004828:Epilepsies, Partial / Q000188:drug therapy / Q000628:therapy*; D004827:Epilepsy; D000078328:Felbamate; D005260:Female; D006801:Humans; D048448:Phenylcarbamates; D011409:Propylene Glycols / Q000627:therapeutic use; D012120:Respiration Disorders / Q000175:diagnosis / Q000209:etiology*; D012129:Respiratory Function Tests; D012893:Sleep Wake Disorders / Q000209:etiology*; D014630:Vagus Nerve / Q000502:physiology*
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D048448:Phenylcarbamates; D011409:Propylene Glycols; D001569:Benzodiazepines; D000078306:Clobazam; D000078328:Felbamate